Pharmaceuticals Inc Regeneron serves as Executive at Avalanche Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Pharmaceuticals Inc Regeneron has executed 3 insider transactions totaling $10.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 5, 2014 involved exercising options for 531,208 shares valued at $0.
Pharmaceuticals Inc Regeneron currently holds 1,220,863 shares of Avalanche Biotechnologies, Inc. (AAVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharmaceuticals Inc Regeneron has been a net buyer of AAVL stock. They have purchased $10.0M and sold $0 worth of shares.
Pharmaceuticals Inc Regeneron's most recent insider trade was on Aug 5, 2014, when they sold 531,208 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $17.00 |
| Discretionary |
| Aug 5, 2014 | AAVL | $0 | Conversion | 689,655 | $N/A | Discretionary |